متابعة
Galen Wright
Galen Wright
Canada Research Chair in Neurogenomics. Assistant Professor, University of Manitoba
بريد إلكتروني تم التحقق منه على umanitoba.ca - الصفحة الرئيسية
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Huntington disease‏
NS Caron, GEB Wright, MR Hayden‏
GeneReviews®[Internet], 2020‏
221*2020
Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease‏
GEB Wright, JA Collins, C Kay, C McDonald, E Dolzhenko, Q Xia, ...‏
The American Journal of Human Genetics 104 (6), 1116-1126, 2019‏
1982019
Nuclear receptor NR1H3 in familial multiple sclerosis‏
Z Wang, AD Sadovnick, AL Traboulsee, JP Ross, CQ Bernales, ...‏
Neuron 90 (5), 948-954, 2016‏
1242016
Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS‏
ABP van Kuilenburg, M Tarailo-Graovac, PA Richmond, BI Drögemöller, ...‏
New England Journal of Medicine 380 (15), 1433-1441, 2019‏
972019
Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation‏
L Warnich, B I Drogemoller, M S Pepper, C Dandara, G EB Wright‏
Current Pharmacogenomics and Personalized Medicine 9 (3), 191-207, 2011‏
932011
The global spectrum of protein-coding pharmacogenomic diversity‏
GEB Wright, B Carleton, MR Hayden, CJD Ross‏
The Pharmacogenomics Journal 18, 187–195, 2018‏
842018
Ethical and legal implications of whole genome and whole exome sequencing in African populations‏
GEB Wright, PGJ Koornhof, AA Adeyemo, N Tiffin‏
BMC Medical Ethics 14 (1), 21, 2013‏
802013
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population‏
C Kay, JA Collins, GEB Wright, F Baine, Z Miedzybrodzka, F Aminkeng, ...‏
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018‏
792018
Pharmacogenomics of vincristine‐induced peripheral neuropathy implicates pharmacokinetic and inherited neuropathy genes‏
GEB Wright, U Amstutz, BI Drögemöller, J Shih, SR Rassekh, MR Hayden, ...‏
Clinical Pharmacology & Therapeutics 105 (2), 402-410, 2019‏
742019
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies‏
GEB Wright, HF Black, JA Collins, T Gall-Duncan, NS Caron, CE Pearson, ...‏
The Lancet Neurology 19 (11), 930-939, 2020‏
672020
SJS/TEN 2019: from science to translation‏
WC Chang, R Abe, P Anderson, W Anderson, MR Ardern-Jones, ...‏
Journal of dermatological science 98 (1), 2-12, 2020‏
662020
Characterization of the Genetic Profile of CYP2C19 in Two South African Populations‏
BI Drögemöller, GEB Wright, DJH Niehaus, L Koen, S Malan, DM Da Silva, ...‏
Pharmacogenomics 11 (8), 1095-1103, 2010‏
662010
Elucidation of CYP2D6 genetic diversity in a unique African population: implications for the future application of pharmacogenetics in the Xhosa population‏
GEB Wright, DJH Niehaus, BI Drögemöller, L Koen, A Gaedigk, L Warnich‏
Annals of Human Genetics 74 (4), 340-350, 2010‏
662010
Association between SLC16A5 genetic variation and cisplatin-induced ototoxic effects in adult patients with testicular cancer‏
BI Drögemöller, JG Monzon, AP Bhavsar, AE Borrie, B Brooks, ...‏
JAMA Oncology 3 (11), 1558-1562, 2017‏
622017
Characterization of the genetic variation present in CYP3A4 in three South African populations‏
BI Drögemöller, M Plummer, L Korkie, G Agenbag, A Dunaiski, D Niehaus, ...‏
Frontiers in Genetics 4, 17, 2013‏
552013
Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study‏
TM Dodgen, WE Hochfeld, H Fickl, SM Asfaha, C Durandt, P Rheeder, ...‏
BMC Medical Genetics 14 (1), 20, 2013‏
542013
A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping‏
D Twesigomwe, GEB Wright, BI Drögemöller, J Da Rocha, Z Lombard, ...‏
NPJ genomic medicine 5 (1), 30, 2020‏
522020
Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients‏
BI Drögemöller, B Brooks, C Critchley, JG Monzon, GEB Wright, G Liu, ...‏
Clinical Cancer Research 24 (8), 1866-1871, 2018‏
502018
Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range‏
H Findlay Black, GEB Wright, JA Collins, N Caron, C Kay, Q Xia, L Arning, ...‏
Genetics in Medicine 22 (12), 2108-2113, 2020‏
492020
Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients‏
M McCormack, H Gui, A Ingason, D Speed, GEB Wright, EJ Zhang, ...‏
Neurology 90 (4), e332-e341, 2018‏
492018
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20